Literature DB >> 21087647

Peptidomic analysis of skin secretions from the bullfrog Lithobates catesbeianus (Ranidae) identifies multiple peptides with potent insulin-releasing activity.

Milena Mechkarska1, Opeolu O Ojo, Mohammed A Meetani, Laurent Coquet, Thierry Jouenne, Yasser H A Abdel-Wahab, Peter R Flatt, Jay D King, J Michael Conlon.   

Abstract

Using a combination of reversed-phase HPLC and electrospray mass spectrometry, peptidomic analysis of norepinephrine-stimulated skin secretions of the American bullfrog Lithobates catesbeianus Shaw, 1802 led to the identification and characterization of five newly described peptides (ranatuerin-1CBb, ranatuerin-2CBc, and -CBd, palustrin-2CBa, and temporin-CBf) together with seven peptides previously isolated on the basis of their antimicrobial activity (ranatuerin-1CBa, ranatuerin-2CBa, brevinin-1CBa, and -1CBb, temporin-CBa, -CBb, and -CBd). The abilities of the most abundant of the purified peptides to stimulate the release of insulin from the rat BRIN-BD11 clonal β cell line were evaluated. Ranatuerin-2CBd (GFLDIIKNLGKTFAGHMLDKIRCTIGTCPPSP) was the most potent peptide producing a significant stimulation of insulin release (119% of basal rate, P<0.01) from BRIN-BD11 cells at a concentration of 30nM, with a maximum response (236% of basal rate, P<0.001) at a concentration of 3μM. Ranatuerin-2CBd did not stimulate release of the cytosolic enzyme, lactate dehydrogenase at concentrations up to 3μM, indicating that the integrity of the plasma membrane had been preserved. Brevinin-1CBb (FLPFIARLAAKVFPSIICSVTKKC) produced the maximum stimulation of insulin release (285% of basal rate, P<0.001 at 3μM) but the peptide was cytotoxic at this concentration. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087647     DOI: 10.1016/j.peptides.2010.11.002

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Serous cutaneous glands in anurans: Fourier transform analysis of the repeating secretory granule substructure.

Authors:  D Nosi; G Delfino; F Quercioli
Journal:  Naturwissenschaften       Date:  2013-01-20

2.  Insights into conformation and membrane interactions of the acyclic and dicarba-bridged brevinin-1BYa antimicrobial peptides.

Authors:  Patrick Brendan Timmons; Donal O'Flynn; J Michael Conlon; Chandralal M Hewage
Journal:  Eur Biophys J       Date:  2019-09-12       Impact factor: 1.733

3.  Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.

Authors:  Opeolu O Ojo; Dinesh K Srinivasan; Bosede O Owolabi; Srividya Vasu; J Michael Conlon; Peter R Flatt; Yasser H A Abdel-Wahab
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

4.  Life history linked to immune investment in developing amphibians.

Authors:  Douglas C Woodhams; Sara C Bell; Laurent Bigler; Richard M Caprioli; Pierre Chaurand; Brianna A Lam; Laura K Reinert; Urs Stalder; Victoria M Vazquez; Klaus Schliep; Andreas Hertz; Louise A Rollins-Smith
Journal:  Conserv Physiol       Date:  2016-08-26       Impact factor: 3.079

5.  Gene expression differs in susceptible and resistant amphibians exposed to Batrachochytrium dendrobatidis.

Authors:  Evan A Eskew; Barbara C Shock; Elise E B LaDouceur; Kevin Keel; Michael R Miller; Janet E Foley; Brian D Todd
Journal:  R Soc Open Sci       Date:  2018-02-28       Impact factor: 2.963

Review 6.  An overview of Brevinin superfamily: structure, function and clinical perspectives.

Authors:  Anna Savelyeva; Saeid Ghavami; Padideh Davoodpour; Ahmad Asoodeh; Marek J Los
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Antimicrobial Peptides from Amphibian Innate Immune System as Potent Antidiabetic Agents: A Literature Review and Bioinformatics Analysis.

Authors:  Hossein Soltaninejad; Hadi Zare-Zardini; Mahtab Ordooei; Yaser Ghelmani; Akram Ghadiri-Anari; Sanaz Mojahedi; Amir Ali Hamidieh
Journal:  J Diabetes Res       Date:  2021-06-29       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.